Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Gordan, Srkalovic"'
Publikováno v:
Biomedicines, Vol 12, Iss 6, p 1328 (2024)
TAFRO (thrombocytopenia (T), anasarca (A), fever (F), reticulin fibrosis (F/R), renal failure (R), and organomegaly (O)) is a heterogeneous clinical subtype of idiopathic multicentric Castleman disease (iMCD) associated with a significantly poorer pr
Externí odkaz:
https://doaj.org/article/ad39503c8f604c31a3f06a18c7c564f0
Autor:
Mateo Sarmiento Bustamante, Sheila K. Pierson, Yue Ren, Adam Bagg, Joshua D. Brandstadter, Gordan Srkalovic, Natalie Mango, Daisy Alapat, Mary Jo Lechowicz, Hongzhe Li, Frits van Rhee, Megan S. Lim, David C. Fajgenbaum
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Idiopathic multicentric Castleman disease (iMCD) is a rare hematologic disorder with heterogeneous presentations ranging from moderate constitutional symptoms to life-threatening multiorgan system involvement. iMCD patients present with vastly differ
Externí odkaz:
https://doaj.org/article/a0b5c548ab2a492e8be1f2a507e118d0
Autor:
Laurie E. Steffen McLouth, Fengmin Zhao, Taofeek K. Owonikoko, Josephine L. Feliciano, Nisha A. Mohindra, Suzanne E. Dahlberg, James L. Wade III, Gordan Srkalovic, Bradley W. Lash, Joseph W. Leach, Ticiana A. Leal, Charu Aggarwal, David Cella, Suresh S. Ramalingam, Lynne I. Wagner
Publikováno v:
Cancer Medicine, Vol 9, Iss 20, Pp 7511-7523 (2020)
Abstract Objectives The ECOG‐ACRIN Cancer Research Group trial E2511 recently demonstrated a potential benefit for the addition of veliparib to cisplatin‐etoposide (CE) in patients with extensive stage small cell lung cancer (ES‐SCLC) in a phas
Externí odkaz:
https://doaj.org/article/50292329a4084b0f8f95400fae2f2d06
Autor:
Hatem Soliman, Varsha Shah, Gordan Srkalovic, Reshma Mahtani, Ellis Levine, Blanche Mavromatis, Jayanthi Srinivasiah, Mohamad Kassar, Robert Gabordi, Rubina Qamar, Sarah Untch, Heather M. Kling, Tina Treece, William Audeh
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-13 (2020)
Abstract Background Increased usage of genomic risk assessment assays suggests increased reliance on data provided by these assays to guide therapy decisions. The current study aimed to assess the change in treatment decision and physician confidence
Externí odkaz:
https://doaj.org/article/87a37eaf5e5243ac9fe1d0dcb516b31f
Autor:
David C, Fajgenbaum, Sheila K, Pierson, Karan, Kanhai, Adam, Bagg, Daisy, Alapat, Megan S, Lim, Mary Jo, Lechowicz, Gordan, Srkalovic, Thomas S, Uldrick, Frits, van Rhee
Publikováno v:
British Journal of Haematology. 198:307-316
Castleman disease (CD) describes a group of rare, potentially fatal lymphoproliferative disorders. To determine factors associated with mortality in CD, we analysed data from deceased patients in the ACCELERATE registry and compared them with matched
Publikováno v:
Acta Medica Academica, Vol 43, Iss 2, Pp 134-143 (2014)
Objective. To analyze factors influencing survival of patients with stage II colon cancer treated at our cancer center (Sparrow Hospital) from February 1996 through December 2006. Patients and methods. Survival analyses on 197 patients’ age 71.1±
Externí odkaz:
https://doaj.org/article/65686f07383b4ef19f9523c025b9d2e8
Autor:
Sheila K Pierson, Mateo Sarmiento Bustamante, Joshua D Brandstadter, Daisy Alapat, Adam Bagg, Mary Jo Lechowicz, Gordan Srkalovic, Megan S. Lim, Frits van Rhee, David C Fajgenbaum
Publikováno v:
Blood. 140:9378-9379
Autor:
Mateo Sarmiento Bustamante, Sheila K Pierson, Yue Ren, Daisy Alapat, Adam Bagg, Joshua D Brandstadter, Mary Jo Lechowicz, Hongzhe Lee, Gordan Srkalovic, Megan S. Lim, Frits van Rhee, David C Fajgenbaum
Publikováno v:
Blood. 140:6520-6521
Autor:
Peter M. Voorhees, Angela Dispenzieri, Alexander Fosså, Amy Chadburn, Megan S. Lim, Makoto Ide, Joshua D Brandstadter, David Wu, Frits van Rhee, Amy D Greenway, Gordan Srkalovic, Wilbur B. Bowne, Thomas S. Uldrick, Sheila K Pierson, Raymond S.M. Wong, Stephen Schey, Mary Jo Lechowicz, Shanmuganathan Chandrakasan, Kazuyuki Yoshizaki, Kojo S.J. Elenitoba-Johnson, Ivan Maillard, Sunita D. Nasta, Razelle Kurzrock, David C. Fajgenbaum, Nikhil C. Munshi, Eric Oksenhendler, Matthew Streetly, Sophia A. T. Parente, Corey Casper
Publikováno v:
Blood Adv
Castleman disease (CD) includes a group of rare and heterogeneous disorders with characteristic lymph node histopathological abnormalities. CD can occur in a single lymph node station, which is referred to as unicentric CD (UCD). CD can also involve
Autor:
Mehran Habibi, Nina D'Abreo, Adam Brufsky, William Audeh, Pat Whitworth, Gordan Srkalovic, Ian Grady, Erin Yoder, Bastiaan van der Baan, Thomas Lomis, Jennifer A. Crozier, Heather M. Kling, Charles E. Cox, Sarah Untch
Publikováno v:
Cancer Research. 80:OT3-17
Background discussion: Genomic signatures are revolutionizing the definition, identification, and treatment of breast cancer. To precisely stratify breast cancers into actionable subgroups, full genome (FG) expression data and matching clinical data